Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice

Molecular Medicine

Volumn 4, Issue 5, 1998, Pages 344-355

  Corry, David B ^b   Grünig, Gabriele ^d   Hadeiba, Husein ^a   Kurup, Viswanath P ^c   Warnock, Martha L ^a   Sheppard, Dean ^a,b   Rennick, Donna M ^d   Locksley, Richard M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALLERGEN; IMMUNOGLOBULIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; B LYMPHOCYTE; BODY PLETHYSMOGRAPHY; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCUS; CONTROLLED STUDY; GOBLET CELL; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031830756     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401741     Document Type: Article

References (67)

1. Walker C, Virchow J-C Jr, Bruijnzeel PLB, Blaser K. (1991) T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146: 1829-1835.
2. Robinson DS, Hamid Q, Ying S, et al. (1992) Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.
3. Leung DYM, Martin RJ, Szefler SJ, et al. (1995) Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J. Exp. Med. 181: 33-40.
4. Wallaert BP, Desreumaux MC, Copin I, et al. (1995) Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J. Exp. Med. 182: 1897-1904.
5. Robinson DS, Tsicopoulos A, Meng Q, Durham S, Kay AB, Hamid Q. (1996) Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am. J. Respir. Cell Mol. Biol. 14: 113-117.
6. Goldstein RA, Paul WE, Metcalfe DD, Busse WW, Reece ER. (1994) Asthma. Ann. Intern. Med. 121: 698-708.
7. Shelhamer, JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SI. (1995) Airway inflammation. Ann. Intern. Med. 123: 288-304.
8. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM. (1996) Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183: 109-117.
9. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10: 587-593.
10. Garlisi CG, Falcone A, Kung TT, et al. (1995) T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin. Immunol. Immunopathol. 75: 75-83.
11. Gonzalo J-A, Lloyd CM, Kremer L, et al. (1996) Eosinophil recruitment to the lung in a murine model of allergic inflammation. J. Clin. Invest. 98: 2332-2345.
12. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R. (1995) Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12: 254-259.
13. Gavett SH, O'Hearn DJ, Karp CL, et al. (1997) Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am. J. Physiol. 272: L253-L261.
14. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. (1997) Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99: 1329-1339.
15. Kotsimbos TC, Ernst P, Hamid QA. (1996) Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc. Assoc. Am. Phys. 108: 368-373.
16. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. (1996) Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4: 313-319.
17. Rankin JA, Picarella DE, Geba GP, et al. (1996) Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. U.S.A. 93: 7821-7825.
18. Drazen JM, Arm JP, Austen KF. (1996) Sorting out the cytokines of asthma. J. Exp. Med. 183: 1-5.
19. Gleich GJ, Kita H. (1997) Bronchical asthma: Lessons from murine models. Proc. Natl. Acad. Sci. U.S.A. 94: 2101-2102.
20. Grunig G, Corry DB, Leach MW, Seymour BWP, Kurup VP, Rennick DM. (1997) Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185: 1089-1099.
21. Wardlaw A, Geddes DM. (1992) Allergic bronchopulmonary aspergillosis: A review. J. R. Soc. Med. 85: 747-751.
22. Kitamura D, Roes J, Kuhn R, Rajewsky K. (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426.
23. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-867.
24. Shinkai Y, Rathbun G, Lam K-P, et al. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
25. Kuhn R, Rajewsky K, Muller W. (1991) Generation and analysis of interleukin-4 deficient mice. Science 254: 707-710.
26. Kopf M, Brombacher F, Hodgkin PD, et al. (1996) IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4: 15-24.
27. Kurup VP, Ramasamy M, Greenberger PA, Fink JN. (1988) Isolation and characterization of a relevant Aspergillus fumigatus antigen with IgG- and IgE-binding activity. Int. Arch. Allergy Appl. Immunol. 86: 176-182.
28. Schumacher JH, O'Garra A, Shrader B, et al. (1988) The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 141: 1576-1581.
29. Ohara J, Paul WE. (1985) Production of a monoclonal antibody to and molecular characterization of B cell stimulatory factor 1. Nature 315: 333-336.
30. Korsgen M, Erjefalt JS, Korsgren O, Sundler F, Persson CGA. (1997) Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J. Exp. Med. 185: 885-892.
31. Hamelmann EA, Vella T, Oshiba A, Kappler JW, Marrack P, Gelfand EW. (1997) Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94: 1350-1355.
32. Shimura S, Andoh Y, Haraguchi M, Shirato K. (1996) Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur. Respir. J. 9: 1395-1401.
33. Bradding P, Feather IH, Howarth PH, et al. (1992) Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176: 1381-1386.
34. Broide DH, Paine MM, Firestein GS. (1992) Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90: 1414-1424.
35. Bradding P, Roberts JA, Britten KM, et al. (1994) Interleukin-4, -5, -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10: 471-480.
36. Burd PR, Thompson WC, Max EE, Mills FC. (1995) Activated mast cells produce interleukin 13. J. Exp. Med. 181: 1373-1380.
37. Nonaka M, Nonaka R, Woolley K, et al. (1995) Distinct immunohistochemical localization of IL-4 in human inflammed airway tissues. J. Immunol. 155: 3234-3244.
38. Nakajima H, Gleich GJ, Kita H. (1996) Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 156: 4859-4866.
39. Moller GM, de Jong TAW, van der Kwast TH, et al. (1996) Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 14: 439-443.
40. Garssen J, Nijkamp FP, Van Der Vliet H, Van Loveren H. (1991) T-cell-mediated induction of airway hyperreactivity in mice. Am. Rev. Respir. Dis. 144: 931-938.
41. + T cells in brown Norway rats. J. Clin. Invest. 96: 1303-1310.
42. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng CX, Drazen JM, Leder P. (1994) Active anaphylaxis in IgE-deficient mice. Nature 370: 367-370.
43. Mehlhop PD, Van de Rijn M, Goldberg AB, et al. (1997) Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl. Acad. Sci. U.S.A. 94: 1344-1349.
44. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C. (1996) Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183: 1303-1310.
45. Eum S-Y, Haile S, Lefort J, Huerre M, Vargaftig BB. 1995. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc. Natl. Acad. Sci. U.S.A. 92: 12290-12294.
46. Oshiba A, Hamelmann E, Takeda K, Bradley KL, Loader JE, Larsen GL, Gelfand EW. (1996) Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97: 1398-1408.
47. Hamelmann E, Oshiba A, Schwarze J, et al. (1997) Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 16: 674-682.
48. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201.
49. Buijs J, Egbers MWEC, Lokhorst WH, Savelkoul HFJ, Nijkamp FP. (1995) Toxocara-induced eosinophilic inflammation. Airway function and effect of anti-IL-5. Am. J. Respir. Crit. Care Med. 151: 873-878.
50. Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP. (1996) Neurogenic amplification of immune complex inflammation. Science 273: 1722-1725.
51. Sylvestre DL, Ravetch JV. (1994) Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science 265: 1095-1098.
52. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. (1994) Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179: 881-887.
53. Gonzalo J-A, Jia G-Q, Aguirre V, et al. (1996) Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 4: 1-14.
54. Kita H, Gleich GJ. (1996) Chemokines active on eosinophils: Potential roles in allergic inflammation. J. Exp. Med. 183: 2421-2426.
55. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P. (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185: 785-790.
56. Stellato C, Collins P, Ponath PD, et al. (1997) Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J. Clin. Invest. 99: 926-936.
57. Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA. (1996) Interleukin-11: Stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97: 915-924.
58. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. 1994. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179: 1145-1154.
59. Franklin W, Goetzl EJ. (1981) Total absence of eosinophils in a patient with an allergic disorder. Ann. Intern. Med. 94: 352-353.
60. Juhlin L, Michaelsson G. (1977) A new syndrome characterized by absence of eosinophils and basophils. Lancet 1: 1233-1235.
61. Lin RY, Lazarus TS. (1995) Asthma and related atopic disorders in outpatients attending an urban HIV clinic. Ann. Allergy Asthma Immunol. 74: 510-515.
62. Locksley RM. (1994) Th2 cells: Help for helminths. J. Exp. Med. 179: 1405-1407.
63. Weiss KB, Gergen PJ, Hodgson TA. (1992) An economic evaluation of asthma in the United States. N. Engl. J. Med. 326: 862-866.
64. Seaton A, Godden DJ, Brown K. (1994) Increase in asthma: A more toxic environment or a more susceptible population? Thorax 49: 171-174.
65. Doull IJ, Lawrence S, Watson M, et al. (1996) Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 153: 1280-1284.
66. Daniels SE, Bhattacharrya S, James A, et al. (1996) A genome-wide search for quantitative trait loci underlying asthma. Nature 383: 247-250.
67. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. (1997) The inverse association between tuberculin responses and atopic disorder. Science 275: 77-79.